# ONCASPAR

NDC: 72694-954
Generic name: Pegaspargase
Labeler / Manufacturer: Servier Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20200102

FDA application: BLA103411

## Active ingredients

- PEGASPARGASE: 750 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72694-954"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72694-954
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac7b6a6f-6ddb-48c6-8088-d8a8e3fea6ce